I think the company is awesome. Great sales growth, profit margin, pipeline, fiscal strength, leadership team, etc. The webcast, however, could have been better. Being on the wrong slide was annoying and it seemed a little disjointed. That may be reflected in the price weakness afterwards. I think approval of their clinical trial, which is expected to happen any day, increased BTM sales, profitability, etc. will be the foundation to resume their strong long term upward trend. Keep the faith.
Company is great...webcast wasn't
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |